Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma.
about
Evaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imagingBiology of hepatocellular carcinomaMorusin shows potent antitumor activity for human hepatocellular carcinoma in vitro and in vivo through apoptosis induction and angiogenesis inhibitionAngiogenesis: multiple masks in hepatocellular carcinoma and liver regeneration.Suppression of angiogenesis and tumor growth in vitro and in vivo using an anti-angiopoietin-2 single-chain antibody.Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib.Fingolimod prevents blood-brain barrier disruption induced by the sera from patients with multiple sclerosis.The effect of Setarud (IMOD(TM)) on angiogenesis in transplanted human ovarian tissue to nude mice.Vascular changes in hepatocellular carcinoma.Clinical significance of vascular endothelial growth factor in hepatitis C related hepatocellular carcinoma in Egyptian patientsReview article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents.Oncogenic function of angiopoietin-2 in vitro and its modulation of tumor progression in colorectal carcinoma.Pericyte-derived glial cell line-derived neurotrophic factor increase the expression of claudin-5 in the blood-brain barrier and the blood-nerve barrier.Peripheral nerve pericytes modify the blood-nerve barrier function and tight junctional molecules through the secretion of various soluble factors.High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.Angiogenesis: from chronic liver inflammation to hepatocellular carcinoma.Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma: implication for antiangiogenic approach to hepatocellular carcinoma.The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin-driven sprouting neovascularization.An intravital microscopic study of the hepatic microcirculation in cirrhotic mice models: relationship between fibrosis and angiogenesis.The antiangiogenic effects of tyroservatide on animal models of hepatocellular carcinoma.The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.Blood-brain barrier destruction determines Fisher/Bickerstaff clinical phenotypes: an in vitro study.Serum levels of angiopoietin-1, angiopoietin-2, and their receptor tie-2 in patients with nonsmall cell lung cancer during chemotherapy.The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors.Histopathological characteristics of hypervascular cholangiocellular carcinoma as an early stage of cholangiocellular carcinoma.Over-expression of the Endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion.Targeting the Tie2-αβ integrin axis with bi-specific reagents for the inhibition of angiogenesis
P2860
Q26783895-EF1B27A5-4E3C-4131-95F8-047EBCCFC706Q28266656-D53A9D7E-739F-4C63-9EA3-FE338995751DQ33826039-ADCA8365-4670-4A48-A235-9B54B5AF1C54Q34130424-6172D579-306C-4B5F-BEA8-F30489CC3E61Q35092548-88A56559-8456-48CB-ADFB-A9037B504900Q35184195-9541ED50-33D7-4A8E-AD5A-0A6910E9BF76Q35578146-D8A9C2D2-4F56-44BE-AA91-B25679948718Q36343247-3019D492-3A0B-4DEA-A449-E9174D692FB9Q37165456-23AAF470-7B4D-48F0-9337-1A3D8AF28DA8Q37197262-0B40D90C-414E-4FDE-A5A4-A14C543DD205Q37276117-CF056816-DE6D-426B-B363-344582D7DB78Q38697673-9E5F9359-641E-4D31-B60D-51129D825A17Q39457264-704103AB-DEDC-4CDA-A8D1-0408C0778ABEQ39674615-58E15FBC-335A-4997-BBAB-C861DD1C84BAQ40227356-B5128EAF-6FB8-4E33-93F9-BBB327E124A1Q40818347-F10FDDA0-E2B1-4857-B7C7-D68FCD99D3B8Q42971014-93A5314C-D5DE-48C5-B186-0B5A9CDD0724Q44014053-28FF9CD8-9849-4EDE-975E-C015D48533EDQ46169180-DF07A2E9-81F2-480F-85B0-06537751E035Q47927563-8E9C5495-63DC-4EB6-81D8-F35571C5FA54Q50350640-B6AA362E-14B6-4496-BE6F-18D0E4CFF406Q51069579-D3407DA8-50C2-4DFD-B103-4AB796E88601Q51739600-B316BDC7-9D2F-4B91-9F70-EEBC840F43C0Q51822856-6F5EE01F-3FE1-4951-8EF9-F038FFF0B608Q53090339-7B759660-B382-4BC4-8F9C-23F9358CBF1DQ54425814-15575A9C-56D9-4FF5-AE01-2E6308688FD6Q56888898-8329C613-412E-4F55-B2BE-F24EE53148CE
P2860
Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Expression of angiopoietins, T ...... n of hepatocellular carcinoma.
@ast
Expression of angiopoietins, T ...... n of hepatocellular carcinoma.
@en
type
label
Expression of angiopoietins, T ...... n of hepatocellular carcinoma.
@ast
Expression of angiopoietins, T ...... n of hepatocellular carcinoma.
@en
prefLabel
Expression of angiopoietins, T ...... n of hepatocellular carcinoma.
@ast
Expression of angiopoietins, T ...... n of hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
Expression of angiopoietins, T ...... n of hepatocellular carcinoma.
@en
P2093
Zhi-Su Liu
Zhong-Lin Zhang
P2860
P304
P356
10.3748/WJG.V12.I26.4241
P407
P577
2006-07-01T00:00:00Z